70961008: Neomycin sulfate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin sulfate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin sulfate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Glycoside (substance)\Aminoglycoside (substance)\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin sulfate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Neomycin sulfate	Is a	Product containing neomycin (medicinal product)	false	Inferred relationship	Some
Neomycin sulfate	Is a	Bactericide	false	Inferred relationship	Some
Neomycin sulfate	Is a	Neomycin (substance)	false	Inferred relationship	Some
Neomycin sulfate	Is a	Substance with aminoglycoside structure and antibacterial mechanism of action (substance)	true	Inferred relationship	Some
Neomycin sulfate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Neomycin (substance)	true	Inferred relationship	Some
Neomycin sulfate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Neomycin sulfate [systemic]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate 5 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate 0.5% single-use eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate 5 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate [ear]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate [skin]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate 25 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neo-tabs 500mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Mycifradin 125mg/5mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neo-fradin 125mg/5mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Chlorhexidine hydrochloride+neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unit/3.5mg/10000unit ophthalmic ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Colistin sulfate + hydrocortisone acetate + neomycin sulfate 3mg/10mg/3.3mg solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unit ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Dexamethasone + neomycin sulfate 1mg/3.5mg ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Dexamethasone sodium phospha + neomycin sulfate 0ns/0ns solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Dexamethasone sodium phosphate + neomycin sulfate 1mg/3.5gm solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/3.5mg/10000 unit suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/7.5mg/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/7.5mg/1000unt solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Colistin sulfate + hydrocortisone acetate + neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing neomycin sulfate and polymyxin B sulfate and zinc bacitracin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Hydrocortisone acetate+neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
médicament contenant dexaméthasone et néomycine et polymyxine B	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing dexamethasone sodium phosphate and neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
allergie au sulfate de néomycine	Causative agent (attribute)	False	Neomycin sulfate	Inferred relationship	Some
Chlorhexidine hydrochloride and neomycin sulfate adverse reaction	Causative agent (attribute)	False	Neomycin sulfate	Inferred relationship	Some	1
Allergy to chlorhexidine hydrochloride and neomycin sulfate	Causative agent (attribute)	False	Neomycin sulfate	Inferred relationship	Some
Clobetasol propionate+neomycin sulfate+Nystatin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate and zinc bacitracin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing clobetasone butyrate and neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
allergie au sulfate de néomycine	Causative agent (attribute)	False	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 0.5% conventional release eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin sulfate	Inferred relationship	Some
Neomycin sulfate 500 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 25 mg/mL oral solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 25 mg/mL oral solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	2
Neomycin sulfate 5 mg/g eye ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 5 mg/g eye ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	1
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	1
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 0.5% conventional release eye drops	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 0.5% conventional release eye drops	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	1
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	2
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	2
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	1
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 5 mg/mL eye drops	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Neomycin sulfate 5 mg/mL eye drops	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Neomycin sulfate	Inferred relationship	Some	1
Allergy to chlorhexidine hydrochloride and neomycin sulfate	Causative agent (attribute)	False	Neomycin sulfate	Inferred relationship	Some	1
Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	2
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	2
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	1
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	1
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	2
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	2
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	2
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin sulfate	Inferred relationship	Some	2
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin sulfate	Inferred relationship	Some	3

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
117867011	Neomycin sulfate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
501730016	Neomycin sulphate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
811074015	Neomycin sulfate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
827531000172117	sulfate de néomycine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
50015211000188114	néomycine sulfate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module